Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 9Dermatologic 8Plasma cell 3Genitourinary 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Tretinoin × Gynecologic × Clear all
NCT01276730 2017-12-29

Advanced Cervical Cancer Trial in India

University of Louisville

Phase 2 Completed
209 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00003598 2010-09-22

IRB 1996-0189

University of Michigan Rogel Cancer Center

Phase NA Completed
180 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡